1. Home
  2. AGBK vs VOR Comparison

AGBK vs VOR Comparison

Compare AGBK & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AGI Inc Class A Common Shares

AGBK

AGI Inc Class A Common Shares

HOLD

Current Price

$7.34

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

SELL

Current Price

$18.04

Market Cap

1.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AGBK
VOR
Founded
1999
2015
Country
Brazil
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
AGBK
VOR
Price
$7.34
$18.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
9
Target Price
$12.50
★ $39.00
AVG Volume (30 Days)
264.6K
★ 1.2M
Earning Date
08-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$58.79
N/A
Revenue Next Year
$34.01
N/A
P/E Ratio
$46.19
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.28
$6.50
52 Week High
$12.21
$30.40

Technical Indicators

Market Signals
Indicator
AGBK
VOR
Relative Strength Index (RSI) 67.07 40.25
Support Level $6.59 $17.35
Resistance Level $7.54 $18.44
Average True Range (ATR) 0.39 1.18
MACD 0.15 0.10
Stochastic Oscillator 87.71 29.33

Price Performance

Historical Comparison
AGBK
VOR

About AGBK AGI Inc Class A Common Shares

AGI Inc is a technology-powered provider of specialized financial services in Brazil. It empowers clients to access their social security benefits, severance fund benefits, and public or private sector payrolls through secured lending solutions and complementary banking, credit and insurance products tailored as per client needs. The company has one operating segment related to the banking business. The Bank provides a standardized set of financial products and services exclusively to individuals, mainly focused on credit, including digital accounts, cards, payroll and personal loans, and insurance offered through partners.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: